**Core Concept:** Immunomodulatory derivatives of thalidomide (IMiDs) are a class of medications that modulate the immune system and have anti-inflammatory and immunomodulatory properties. They are used primarily in the treatment of certain types of haematological malignancies, such as multiple myeloma and some lymphomas.

**Why the Correct Answer is Right:** Pomalyst (also known as pomalidomide) is a prominent member of the IMiDs class. It acts as an immunomodulatory agent, binding to cereblon and leading to the degradation of Ikaros and Aiolos proteins. This results in inhibition of cellular proliferation, induction of apoptosis in cancer cells, and enhancement of the immune system's ability to recognize and eliminate cancer cells.

**Why Each Wrong Option is Incorrect:**

A. Lenalidomide (Revlimid) is another IMiD medication, but it is not mentioned in the question. It is more commonly used in the treatment of multiple myeloma and is not as effective as Pomalyst in treating certain peripheral T-cell lymphomas.

B. Thalidomide (Contergan) is the original thalidomide drug, which has several adverse effects including neuropathy and respiratory depression. It is not specifically used for treating haematological malignancies and has been largely discontinued due to its severe side effects.

C. Thalidomide is another thalidomide drug, similar to option B. It is not specific to haematological malignancies and has severe side effects, making it unsuitable for treating lymphomas.

D. Revlimid (Lenalidomide) is a different IMiD drug, not mentioned in the question but relevant to the topic. It is more commonly used in the treatment of multiple myeloma, not peripheral T-cell lymphomas, which is the intended target for Pomalyst.

**Clinical Pearl:** The clinical use of IMiDs, including Pomalyst, is based on their ability to modulate the immune system and enhance its function against haematological malignancies. However, the specific choice of drug depends on the type and stage of the cancer being treated. For treating peripheral T-cell lymphoma, Pomalyst is a more suitable option than the other mentioned drugs.